Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Jinrui Pharmaceutical Co., Ltd. is a pharmaceutical company based in Haikou, Hainan, China, specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 2008, the company focuses on oncology, cardiovascular diseases, pain management, and infectious diseases. Its product portfolio includes a range of sterile injections and oral medications, such as Pemetrexed Disodium, Fludarabine Phosphate, Oxaliplatin, and Diltiazem Hydrochloride. Hainan Jinrui operates manufacturing facilities in the Haikou Free Trade Zone and provides contract manufacturing and technology transfer services. The company is recognized for its expertise in freeze-dried powder injection technology and chemical API synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Jinrui Pharmaceutical.